Cell And Gene Therapy Videos

  1. Pace Life Sciences Capacity Update October 2025: Fill/Finish 10/20/2025

    Our experts and investment in state-of-the-art development and manufacturing facilities underscore our commitment to advancing programs from the clinic to commercialization.

  2. The Future Of Lentiviral Vector Innovation And Access 10/17/2025

    Founded on lentiviral vector design and manufacturing excellence, VBM and the LENTIVERSE™ technology platform provide a full suite of tools to quickly deliver state-of-the-art therapies and develop next-generation products.

  3. Minaris Advanced Therapies Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    During this session, we will provide an overview of our capabilities, including our contract testing services, and an update on our current capacity.

  4. Ascend & ABL Inc. Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    Operating from state-of-the-art GMP facilities, we provide end-to-end services to commercial, academic, and government clients, spanning process innovation through development, GMP manufacturing, QC testing, to aseptic fill/finish.

  5. Andelyn Biosciences Capacity Update October 2025: Cell & Gene Therapy 10/17/2025

    A risk-based framework for identity testing of ancillary raw materials in gene therapy is presented, with emphasis on implementation based on product contact, material classification, and manufacturing stage.

  6. Streamline Biopharmaceutical Manufacturing With Versatile Platforms 10/16/2025

    Gain insights into how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.

  7. Effective Supply Chain And QC Testing Through Collaborative Partnerships 9/30/2025

    Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.

  8. Utilizing Flow Cytometry For Humoral Immunogenicity Testing: Cell & Gene Therapy 9/29/2025

    Discover strategies to overcome immunogenicity challenges in cell and gene therapies, with a focus on harnessing flow cytometry to enhance ADA and NAb assay development, strengthen validation, and ensure regulatory readiness.

  9. A CAR T Outsourcing Case Study 9/23/2025

    Firelli Alonso, former and long-time Senior Director of External Supply at Pfizer, now industry consultant, provides an example of outsourcing in the CAR T space to demonstrate what can go right and not so right.

  10. Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months 9/17/2025

    Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.